Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy

• Autori principali: Blair McNamara (Autore), Stefania Bellone (Autore), Cem Demirkiran (Autore), Tobias Max Philipp Hartwich (Autore), Alessandro D. Santin (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2023-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Treatment of uterine serous carcinoma (USC) is challenging; effective treatment options for metastatic and recurrent disease are needed. Case: A 68-year-old woman with recurrent, metastatic, USC overexpressing HER2/neu experienced durable response to the antibody drug conjugate (ADC) tra...